Average Co-Inventor Count = 4.70
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Dyax Corporation (23 from 173 patents)
2. Bracco Suisse Sa (9 from 59 patents)
3. Bracco International Bv (2 from 108 patents)
4. Seagen Inc. (1 from 64 patents)
5. Takeda Pharmaceutical Company Limited (1,179 patents)
24 patents:
1. 11253609 - Glycan-interacting compounds and methods of use
2. 10314909 - Combination therapy comprising an MMP-14 binding protein
3. 9845340 - Peptides that specifically bind HGF receptor (cMet) and uses thereof
4. 9629934 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
5. 9446155 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
6. 9056138 - Multivalent constructs for therapeutic and diagnostic applications
7. 9051377 - Method for treating breast cancer using antibody binding to MMP-14
8. 9000124 - Peptides that specifically bind HGF receptor (cMet) and uses thereof
9. 8663603 - Multivalent constructs for therapeutic and diagnostic applications
10. 8642010 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
11. 8632753 - Multivalent constructs for therapeutic and diagnostic applications
12. 8501181 - Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins
13. 8183008 - Evaluating MMP expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancer
14. 8147836 - Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins
15. 8106168 - Metalloproteinase binding proteins